Research Program, Women's Cancer
Assistant Professor, Department of Obstetrics, Gynecology and Women's Health, Division of Gynecologic Oncology

jonso001@umn.edu
612-626-3111— office

Dr. Jonson's clinical profile
(University of Minnesota Physicians Web site)

Dr. Jonson graduated magna cum laude with a degree in biology from Creighton University. She received her M.D. degree from Creighton University School of Medicine and completed her residency in obstetrics and gynecology at the University of Minnesota, where she also conducted a fellowship in gynecologic oncology. In 2007, after practicing in Washington, D.C., at Georgetown University Hospital and the Washington Hospital Center, Dr. Jonson returned to join the faculty in the Department of Obstetrics, Gynecology and Women's Health at the University of Minnesota.

Research Interests

1. Translational research in ovarian, uterine and cervical cancers
2. Human papilloma virus and cervix cancer
3. Carcinosarcomas

Selected Publications

Judson PL, Jonson AL, Paley PJ, Bliss RL, Murray KP, Downs LS Jr, Boente MP, Argenta PA and Carson LF. A Prospective, Randomized Study Analyzing Sartorius Transposition Following Inguinal-Femoral Lymphadenectomy. Gynecol Oncol. 2004 ;95:226-230.

Jonson A, Truskinovsky A, Bliss R, Judson P, Argenta P, Carson L and Downs L. Clinical Features and Detection of Uterine and Ovarian Carcinosarcoma. Gynecol Oncol. 2006;100:561-564.

Jonson AL. Development of the human papillomavirus vaccine and guidelines for its use. Virtual Mentor. 2007; 9:30-33.

Bijelic L, Jonson A, Sugarbaker P. Systematic Review of Cytoreductive Surgery and Heated Intraoperative Intraperitoneal Chemotherapy for Treatment of Peritoneal Carcinomatosis in Primary and Recurrent Ovarian Cancer. Ann Oncol. 2007;18:1943-1950.

Jonson AL, Rogers LM, Ramakrishnan S, Downs LS Jr. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Gynecol Oncol. 2008;111:356-364.

Argenta PA, Thomas SG, Judson PL, Downs LS Jr, Geller MA, Carson LF, Jonson AL, Ghebre R. A Phase II study of fulvestrant in the treatment of multiply-recurrent epithelial ovarian cancer. Gynecol Oncol. 2009;113:205-209.

Ivy JJ, Geller M, Pierson SM, Jonson AL, Argenta PA. Detection associated with different intraperitoneal chemotherapy delivery systems in advanced ovarian carcinoma: a single institution's experience. Gynecol Oncol. 2009;114:420-423.

Jonson AL, Geller MA, Dickson EL. Gonadal dysgenesis and gynecologic cancer. Obstet Gynecol.  2010;116(Suppl 2):550-552.

Geller MA, Downs LS, Judson PL, Ghebre R, Argenta PA, Carson LF, Jonson AL, Godfrey K, Vogel RI, Petzel SV. Learning about ovarian cancer at the time of diagnosis: Video versus usual care. Gynecol Oncol. 2010;119:370-375.

Geller MA, Cooley S, Judson PL, Ghebre R, Carson LF, Argenta PA, Jonson AL, Panoskaltsis-Mortari A, Curtsinger J, McKenna D, Dusenbery K, Bliss R, Downs LS, Miller JS. A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer. Cytotherapy 2011;13:98-107.

Geller MA, Ivy JJ, Ghebre R, Downs LS Jr, Judson PL, Carson LF, Jonson AL, Dusenbery K, Vogel RI, Boente MP, Argenta PA. A phase II trial of carboplatin and docetaxel followed by radiotherapy given in a "sandwich" method for stage III, IV, and recurrent endometrial cancer. Gynecol Oncol. 2011;121:112-117.